Showing results (31-40 of 174) with videos related to
Sort By:
Pageof 18
Plos One|June 12, 2026
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitroChelsea Gootjes, Jaap Jan Zwaginga, Tatjana Nikolic, et al.Cells|June 19, 2024
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with FunctionChelsea Gootjes, Jaap Jan Zwaginga, Bart O Roep, et al.Nature Reviews. Endocrinology|December 9, 2020
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)Bart O Roep, Sofia Thomaidou, René van Tienhoven, et al.Frontiers in Immunology|May 23, 2022
Functional Impact of Risk Gene Variants on the Autoimmune Responses in Type 1 DiabetesChelsea Gootjes, Jaap Jan Zwaginga, Bart O Roep, et al.Plos One|January 4, 2013
Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cellsKarsten Buschard, Jan-Eric Månsson, Bart O Roep, et al.Current Opinion in Immunology|October 11, 2016
A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetesBart O Roep, Maria Jl Kracht, Menno van Lummel, et al.Plos One|January 26, 2023
Low risk for diabetic complications in type 1 diabetes patients carrying a protective insulin gene variantRené van Tienhoven, Anh Nguyet Vu, John S Kaddis, et al.Clinical and Experimental Rheumatology|October 13, 2015
Inducing tissue specific tolerance in autoimmune disease with tolerogenic dendritic cellsJessica S Suwandi, René E M Toes, Tatjana Nikolic, et al.Diabetes Care|July 4, 2020
Anti-PD-1 Therapy-Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin LymphomaRaynald A Samoa, Hayley S Lee, Sung H Kil, et al.Current Diabetes Reports|May 12, 2016
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes PathogenesisRene J McLaughlin, Matthew P Spindler, Menno van Lummel, et al.Pageof 18